410 related articles for article (PubMed ID: 29187904)
1. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
[No Abstract] [Full Text] [Related]
2. In Vivo Magnetic Resonance and Fluorescence Dual-Modality Imaging of Tumor Angiogenesis in Rats Using GEBP11 Peptide Targeted Magnetic Nanoparticles.
Su T; Wang Y; Wang J; Han D; Ma S; Cao J; Li X; Zhang R; Qiao H; Liang J; Liu G; Yang B; Liang S; Nie Y; Wu K; Li J; Cao F
J Biomed Nanotechnol; 2016 May; 12(5):1011-22. PubMed ID: 27305822
[TBL] [Abstract][Full Text] [Related]
3. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles.
Wang Y; Chen J; Yang B; Qiao H; Gao L; Su T; Ma S; Zhang X; Li X; Liu G; Cao J; Chen X; Chen Y; Cao F
Theranostics; 2016; 6(2):272-86. PubMed ID: 26877785
[TBL] [Abstract][Full Text] [Related]
4. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
[TBL] [Abstract][Full Text] [Related]
5. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe
Qiao H; Wang Y; Zhang R; Gao Q; Liang X; Gao L; Jiang Z; Qiao R; Han D; Zhang Y; Qiu Y; Tian J; Gao M; Cao F
Biomaterials; 2017 Jan; 112():336-345. PubMed ID: 27788352
[TBL] [Abstract][Full Text] [Related]
6. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
[TBL] [Abstract][Full Text] [Related]
7. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
8. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
[TBL] [Abstract][Full Text] [Related]
9. Novel PET Imaging of Atherosclerosis with 68Ga-Labeled NOTA-Neomannosylated Human Serum Albumin.
Kim EJ; Kim S; Seo HS; Lee YJ; Eo JS; Jeong JM; Lee B; Kim JY; Park YM; Jeong M
J Nucl Med; 2016 Nov; 57(11):1792-1797. PubMed ID: 27339872
[TBL] [Abstract][Full Text] [Related]
10. Detecting Vulnerable Atherosclerotic Plaques by
Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
[TBL] [Abstract][Full Text] [Related]
11. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility of targeted magnetic resonance imaging on visualizing tenascin-C expression in atherosclerosis plaque in high-fat diet fed ApoE(-/-) mice].
Meng H; Ma ZL; Yan HL; Chen XX; Shang SA; Yu J; Song JC; Shi HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):342-7. PubMed ID: 27112614
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z
Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
[TBL] [Abstract][Full Text] [Related]
15. [
Li X; Yu W; Wollenweber T; Lu X; Wei Y; Beitzke D; Wadsak W; Kropf S; Wester HJ; Haug AR; Zhang X; Hacker M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1616-1625. PubMed ID: 31004184
[TBL] [Abstract][Full Text] [Related]
16. Imaging High-Risk Atherothrombosis Using a Novel Fibrin-Binding Positron Emission Tomography Probe.
Izquierdo-Garcia D; Diyabalanage H; Ramsay IA; Rotile NJ; Mauskapf A; Choi JK; Witzel T; Humblet V; Jaffer FA; Brownell AL; Tawakol A; Catana C; Conrad MF; Caravan P; Ay I
Stroke; 2022 Feb; 53(2):595-604. PubMed ID: 34965737
[TBL] [Abstract][Full Text] [Related]
17. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
[TBL] [Abstract][Full Text] [Related]
18. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer
Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M
J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718
[No Abstract] [Full Text] [Related]
19. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
20. PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation.
Ripa RS; Pedersen SF; Kjær A
PET Clin; 2016 Oct; 11(4):479-88. PubMed ID: 27593251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
